ENZYMOTEC LTD's ticker is ENZY and the CUSIP is M4059L101. A total of 37 filers reported holding ENZYMOTEC LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $546,000 | -47.5% | 46,046 | -71.0% | 0.00% | – |
| Q4 2016 | $1,040,000 | -83.8% | 158,803 | -82.7% | 0.00% | -100.0% |
| Q3 2016 | $6,416,000 | -32.3% | 916,608 | -19.1% | 0.00% | -33.3% |
| Q2 2016 | $9,474,000 | +12.5% | 1,133,214 | +21.5% | 0.00% | 0.0% |
| Q1 2016 | $8,423,000 | -11.3% | 932,755 | -3.7% | 0.00% | 0.0% |
| Q4 2015 | $9,496,000 | +10.7% | 969,027 | +2.2% | 0.00% | 0.0% |
| Q3 2015 | $8,577,000 | +41.6% | 947,723 | +30.6% | 0.00% | +50.0% |
| Q2 2015 | $6,059,000 | +852.7% | 725,612 | +721.5% | 0.00% | – |
| Q1 2015 | $636,000 | +162.8% | 88,331 | +178.8% | 0.00% | – |
| Q4 2014 | $242,000 | -0.8% | 31,684 | -13.4% | 0.00% | – |
| Q3 2014 | $244,000 | -64.3% | 36,571 | -27.4% | 0.00% | – |
| Q2 2014 | $684,000 | -39.1% | 50,369 | -1.3% | 0.00% | – |
| Q1 2014 | $1,123,000 | -35.3% | 51,020 | -20.6% | 0.00% | -100.0% |
| Q4 2013 | $1,735,000 | – | 64,251 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 130,313 | $2,404,000 | 1.99% |
| TIGER MANAGEMENT L.L.C. | 677,548 | $4,438,000 | 0.80% |
| Paulson & Co. | 4,205,980 | $27,549,000 | 0.35% |
| ALGERT GLOBAL LLC | 50,566 | $331,000 | 0.10% |
| GAGNON SECURITIES LLC | 377,302 | $194,000 | 0.08% |
| MENTA CAPITAL LLC | 49,029 | $321,000 | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 229,862 | $1,506,000 | 0.01% |
| Laurion Capital Management LP | 109,913 | $720,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 11,300 | $74,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 4,831 | $32,000 | 0.00% |